Nutrition Research
Volume 23, Issue 1 , Pages 67-75 , January 2003

Effects of soy isoflavone supplementation on plasma glucose, lipids, and antioxidant enzyme activities in streptozotocin-induced diabetic rats

  • Chun-Sen Hsu

      Affiliations

    • Department of Obstetrics and Gynecology, Taipei Medical University-affiliated Wan-Fang Hospital, Taipei, Taiwan, ROC
    • ,
  • Wan-Chun Chiu

      Affiliations

    • School of Nutrition and Health Science, Taipei Medical University, Taipei, Taiwan, ROC
    • ,
  • Sung-Ling Yeh

      Affiliations

    • School of Nutrition and Health Science, Taipei Medical University, Taipei, Taiwan, ROC
    • Corresponding Author InformationCorresponding author. Tel.: +8862-27361661; fax: +8862-27373112.

Received 10 October 2001 ,Revised 15 October 2001 ,Accepted 16 October 2001.

References 

  1. Setchell KDR. Phytoestrogens (the biochemistry, physiology, and implications for human health of soy isoflavones). Am J Clin Nutr. 1998;68(suppl):1333S–1346S
  2. Anthony MS, Clarkson TB, Williams JK. Effects of soy isoflavones on atherosclerosis (potential mechanism). Am J Clin Nutr. 1998;68:1390S–1393S
  3. Potter SM. Overview of proposed mechanisms for the hypocholesterolemic effect of soy. J Nutr. 1995;125:606S–611S
  4. Anthony MS, Clarkson TB, Hughes CL, Morgan TM, Burke GL. Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal Rhesus monkey. J Nutr. 1996;126:43–50
  5. Huff MW, Roberts DCK, Carroll KK. Long-term effects of semipurified diets containing casein of soy protein isolate on atherosclerosis and plasma lipoproteins in rabbits. Atherosclerosis. 1982;41:327–336
  6. Cook NC, Samman S. Flavonoids–chemistry, metabolism, cardioprotective effects, and dietary sources. J Nutr Biochem. 1996;7:66–76
  7. Hodgson JM, Croft KD, Puddey IB, Mori TA, Beilin LJ. Soybean isoflavonoids and their metabolic products inhibit in vitro lipoprotein oxidation in serum. J Nutr. 1996;7:664–669
  8. Vinson JA, Dabbagh YA, Serry MM, Jang J. Plant flavonoids, especially tea flavonols, are powerful antioxidants using an in vitro oxidation model for heart disease. J Agric Food Chem. 1995;43:2800–2802
  9. Brown WV. Lipoprotein disorders in diabetes mellitus. Med Clin N Am. 1994;78:143–161
  10. Kannel WB, McGee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease (the Framingham Study). Diabet Care. 1979;2:120–126
  11. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabet Care. 1993;15:434–444
  12. Noorouz-Zadeh J, Rahimi A, Tajaddini-Sarnadi J, Tritschler H, Rosen P, Halliwell B, et al. Relationships between plasma measures of oxidative stress and glycemic control in NIDDM. Diabetologia. 1997;40:647–653
  13. Haffner SM, Agil A, Mykkanen L, Stern MP, Jialal I. Plasma oxidizability in subjects with normal glucose tolerance, impaired glucose tolerance and NIDDM. Diabet Care. 1995;18:646–652
  14. Sato Y, Hotta N, Sakamoto N, Matsuoka S, Ohishin N, Yaki K. Lipid peroxide level in plasma of diabetic patients. Biochem Med. 1979;21:104–107
  15. Jennings PE, Jones AF, Florkowski CM, Lunec J, Barnett H. Increased diene conjugates in diabetic subjects with microangiopathy. Diabet Med. 1987;4:452–456
  16. MacRury SM, Gordon D, Wilson R, Bradley H, Gemmell CG, Paterson JR, et al. Comparison of different methods of assessing free radical activity in type 2 diabetes and peripheral vascular disease. Diabet Med. 1993;10:331–335
  17. Haffner SM. Clinical relevance of the oxidative stress concept. Metabolism. 2000;49:30–34
  18. Sharma A, Kharb S, Chugh SN, Kakkar R, Singh GP. Evaluation of oxidative stress before and after control of glycemia and after vitamin E supplementation in diabetic patients. Metabolism. 2000;49:160–162
  19. Baynes JW, Thorpe SR. Role of oxidative stress in diabetic complications (a new perspective on an old paradigm). Diabetes. 1999;48:1–9
  20. Liu Y, Thronton JD, Cohen MV, Downey JM, Schaffer SW. Streptozotocin-induced non-insulin-dependent diabetes protects the heart from infarction. Circulation. 1993;88:1273–1278
  21. Ebara T, Hirano T, Mamo JC, Sakamaki R, Furukawa S, Nagano S, et al. Hyperlipidemia in streptozotocin-diabetic hamsters as a model for human insulin-deficient diabetes (comparison to streptozotocin diabetic rats). Metabolism. 1994;43:299–305
  22. Skett P, Joles A. Different effects of acute and chronic diabetes mellitus on hepatic drug metabolism in the rat. Biochem Pharmacol. 1985;34:287–289
  23. Canepa ET, Llambias EBC, Grinstein M. Studies on regulatory mechanisms of heme biosynthesis in hepatocytes from normal and experimental-diabetic rats. Role of insulin. Biochem Cell Biol. 1990;68:914–921
  24. Warnick GR, Benderson J, Albers JJ. Dextran sulfate-Mg+2 precipitation procedure for quantitation of high density lipoprotein-cholesterol. Clin Chem. 1982;28:1379–1388
  25. Friedewald WT, Levy RE, Frederickson DS. Estimation on the concentration of low density lipoprotein cholesterol in plasma without use of the ultracentrifuge. Clin Chem. 1972;18:499–502
  26. Yeh SL, Chang KY, Huang PC, Chen WJ. Effects of n-3 and n-6 fatty acids on plasma eicosanoids and liver antioxidant enzymes in rats receiving total parenteral nutrition. Clin Nutr. 1997;13:32–36
  27. Lowry OH, Rosebrough NJ, Farr AC, et al.  Protein measurement with the folin-phenol reagent. J Biol Chem. 1951;193:265–275
  28. Uchiyama M, Mihara M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Chem. 1978;86:271–278
  29. Hu ML, Frankel EN, Leibovitz BE, Tappel AL. Effect of dietary lipids and vitamin E on in vitro lipid peroxidation in rat liver and kidney homogenates. J Nutr. 1989;119:1574–1582
  30. Gonzales R, Auclair C, Voisin E, Gautero H, Dhermy D, Boivin P. Superoxide dismutase, catalase, and glutathione peroxidase in red blood cells from patients with malignant disease. Cancer Res. 1984;44:4137–4139
  31. Hsu CS, Shen WW, Hsueh YM, Yeh SL. Soy isoflavone supplementation in postmenopausal women (effects on plasma lipids, antioxidant enzyme activities and bone density). J Reprod Med. 2001;46:221–226
  32. Chait A. Effects of isoflavones on LDL-cholesterol in vitro but not in vivo. Am J Clin Nutr. 1998;68(suppl):1521S; (abstr)
  33. Tumbelake SL, Sajuthi JS. The lack of effect of isoflavone on plasma lipid concentrations in ovariectomized cynomolgus monkeys and LDL susceptibility to oxidation. Am J Clin Nutr. 1998;68(suppl):1521S; (abstr)
  34. UK Prospective Diabetes (UKPDS) Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet. 1998;352:837–853
  35. Potter SM, Baum J, Teng H, Stillman RJ, Shay NF, Hoffman JW. Soy protein and isoflavones (their effects on blood lipids and bone density in postmenopausal women). Am J Clin Nutr. 1998;68(suppl):1375S–1379S

PII: S0271-5317(02)00386-X

Nutrition Research
Volume 23, Issue 1 , Pages 67-75 , January 2003

Article Tools